NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
19.56
-0.50 (-2.49%)
Nov 2, 2026, 4:00 PM EST - Market closed
NAMS Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citi | Citi | Buy Maintains $55 | Buy | Maintains | $55 | +181.19% | Oct 15, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $50 → $42 | Buy | Maintains | $50 → $42 | +114.72% | Oct 5, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $55 | Buy | Maintains | $55 | +181.19% | Oct 2, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $52 | Buy | Reiterates | $52 | +165.85% | Sep 29, 2026 |
| Truist Financial | Truist Financial | Buy Reiterates $57 | Buy | Reiterates | $57 | +191.41% | Sep 22, 2026 |
| BMO Capital | BMO Capital | Buy Maintains $58 | Buy | Maintains | $58 | +196.52% | Sep 22, 2026 |
| William Blair | William Blair | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Sep 18, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $50 | Buy | Maintains | $50 | +155.62% | Sep 8, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.